Streetwise Medical Devices Articles


News Update

Developer of Nitric Oxide Delivery Devices Rebrands to Focus on Leading Advancements

News Update
  ()
This Utah-based company rolled out an online campaign that highlights its strategic repositioning. read more >

Company with Cancer Radiotherapy Grows Revenue for Six Consecutive Quarters

Research Report
  ()
An H.C. Wainwright & Co. report reviewed this company's Q4/18 earnings and opportunities for increasing it. read more >

Surgical Robotics Developer Demonstrates Technology at Medical Conference

Research Report
  ()
A Ladenburg Thalmann report relayed how this Massachusetts company participated at the Transcatheter Cardiovascular Therapeutics annual meeting through a live transmission—the first ever—of a remote interventional procedure using the CorPath GRX system. read more >

Coverage Initiated on Firm with Paradigm-Shifting Colonoscopy Device

Research Report
  ()
A Ladenburg Thalmann report covered the asset, product market and financial projections of this Florida-based company. read more >

Medical Device Firm's Clinical Programs Progress in Q2/18

Research Report
  ()
A Ladenburg Thalmann report reviewed the recent financial results for a California-based company that has developed treatments for vaginal laxity and female stress urinary incontinence. read more >

Medical Device Firm Anticipates Benefit from Patent Ruling

  ()
This company, which develops delivery products for inhaled nitric oxide, a gas used to treat newborns with low oxygen levels and patients with COPD, sees opportunity in a newly invalidated patent. read more >

Interim Readout for Pharma Trial 'Delivers Home Run'

Research Report
  ()
An H.C. Wainwright & Co. report discussed the implications of data indicating "overwhelming evidence of efficacy" for this company's nonantibiotic anti-infective for treatment of catheter-related bloodstream infections. read more >

Agreement Facilitates Progress Toward Medical Device Approvals

  ()
This medical device company enters a partnership to provide quality and regulatory services. read more >

Coverage Initiated on Developer of Women's Reproductive Health Products

Research Report
  ()
A ROTH Capital Partners research report outlined the key drivers of the investment thesis for this firm. read more >

Analyst: 'New CEO, Larger Sales Team and Greater SUI Focus Should Help Medical Device Growth'

Research Report
  ()
Cowen analyst Dr. Joshua Jennings highlighted this medical device firm’s Q1/18 developments and financial results. read more >

What Stephen Hawking Missed: Small Biotechs Developing Promising Cell Therapies for Devastating Disease

  ()
In the second of a two-part series exploring the disruptive cell therapy space, Maxim Group analyst Jason McCarthy takes a look at small-cap companies targeting big-ticket indications and their potential to drive blockbuster value for both patients and investors. read more >
Showing Results: 1 to 11 of 11

Get Our Streetwise Reports Resources Report Newsletter Free and be the first to know!

A valid email address is required to subscribe

More Experts

"At Snowstorm, SEA should identify drill targets by year-end." ❭
– Jim Marrone, SingularResearch
"CYP could mine rare earths, possibly lucratively, at Clayton Valley." ❭
– Rick Mills, Ahead of the Herd
"GPR will acquire all the outstanding shares of Beadell for AU$144M." ❭
– Bhakti Pavani, Alliance Global Partners
"TXR added the Tom mine and Sickle properties to Yellowknife City." ❭
– Brien Lundin, Gold Newsletter (Jefferson Financial)
"GPLY should crank out the news flow in the weeks and months ahead." ❭
– Brien Lundin, Gold Newsletter (Jefferson Financial)